tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Molecular Partners price target lowered to CHF 3 from CHF 3.50 at JPMorgan
PremiumThe FlyMolecular Partners price target lowered to CHF 3 from CHF 3.50 at JPMorgan
2M ago
Molecular Partners price target lowered to $3.75 from $4 at JPMorgan
Premium
The Fly
Molecular Partners price target lowered to $3.75 from $4 at JPMorgan
2M ago
Molecular Partners presents updated data from Phase 1/2a trial of MP0533
Premium
The Fly
Molecular Partners presents updated data from Phase 1/2a trial of MP0533
2M ago
Molecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
PremiumRatingsMolecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
5M ago
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
Premium
Ratings
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
5M ago
Molecular Partners Reports H1 2025 Progress and Financial Stability
Premium
Company Announcements
Molecular Partners Reports H1 2025 Progress and Financial Stability
5M ago
Molecular Partners to preent updated data from MP0533 trial at EHA congress
PremiumThe FlyMolecular Partners to preent updated data from MP0533 trial at EHA congress
8M ago
Molecular Partners: Strategic Restructuring and Financial Stability Drive Buy Rating
Premium
Ratings
Molecular Partners: Strategic Restructuring and Financial Stability Drive Buy Rating
8M ago
Molecular Partners to reduce workforce by 24%
Premium
The Fly
Molecular Partners to reduce workforce by 24%
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100